Background--Genetic causes of dilated cardiomyopathy (DCM) are incompletely understood. LRRC10 (leucine-rich repeatcontaining 10) is a cardiac-specific protein of unknown function. Heterozygous mutations in LRRC10 have been suggested to cause DCM, and deletion of Lrrc10 in mice results in DCM.
D
ilated cardiomyopathy (DCM), characterized by left ventricular dilation and systolic dysfunction, is a leading cause of heart failure and premature death. Consequently, DCM is the most common indication for cardiac transplantation in both children and adults. 1, 2 Seminal work establishing idiopathic DCM as a familial disorder in 20% to 48% of cases [3] [4] [5] has led to DCM gene discovery, culminating in the identification of >50 DCM-associated genes. 6 Inheritance of many diseasecausing mutations does not translate into symptomatic heart failure until the fifth decade of life, owing to age-dependent penetrance. Recently, LRRC10 was selected as a candidate gene for mutation scanning in a cohort of 220 DCM patients, based on its cardiac-restricted expression and animal knockout studies. Two heterozygous missense mutations were identified (L41V and L163I), associating LRRC10 with adult-onset, familial DCM segregating as an autosomal dominant trait. 7 Leucine-rich repeats (LRRs) are 20-to 29-residue sequence motifs present in many proteins with diverse biological functions and cellular locations. 8 The crystal structure of the porcine ribonuclease inhibitor protein, composed of 15 LRRs, illustrates their solenoid conformation ideal for protein-protein interactions. 9 LRR-containing proteins have been shown to regulate ion channel function by modulating their biophysical properties. [10] [11] [12] [13] LRRC10 (LRR-containing 10) is a cardiacspecific factor in zebrafish, mice, and humans. [14] [15] [16] [17] Knockdown of lrrc10 in zebrafish results in heart failure and embryonic lethality. 17 Knockout of Lrrc10 in mice leads to prenatal systolic dysfunction and postnatal DCM. 18, 19 These findings indicate that LRRC10 plays a critical role across species in maintaining normal cardiac function. However, the mechanism by which LRRC10 regulates cardiac function and how mutation or knockout of LRRC10 leads to DCM are unknown. Localization of LRRC10 to the dyad region of adult cardiomyocytes 16 suggests it may regulate cardiac ion channels such as L-type Ca 2+ channel (LTCC). We used whole-exome sequencing (WES) to discover a homozygous recessive variant in the LRR region of LRRC10 in a sporadic case of pediatric DCM. We provide comprehensive characterization of LRRC10 and the DCM-associated substitution, I195T, revealing its unique impact on the modulation of cardiac LTCCs using both heterologous expression and native cardiomyocyte systems.
Materials and Methods
Because of the sensitive and confidential nature of the clinical and genetic patient data collected for this study, requests for data access will be restricted to deidentified Sanger sequencing data from qualified researchers following approval by the Mayo Clinic institutional review board. Requests may be sent to Dr Timothy M. Olson at the Mayo Clinic. The cDNA constructs used for heterologous expression studies and the mouse model can be provided to qualified researchers upon request to Dr Timothy Kamp at the University of Wisconsin-Madison.
Study Participants
Participants provided written informed consent under a research protocol approved by the Mayo Clinic institutional review board. Diagnostic criteria for DCM were left ventricular diastolic and/or systolic dimensions >95th percentile indexed for body surface area and left ventricular ejection fraction <50% as determined by echocardiography. Genomic DNA was isolated from peripheral blood white cells or saliva. WES and whole-genome sequencing data from 115 in-house individuals not affected with DCM were used for subtraction filtering of exome variant calls to identify true positives.
Array Comparative Genomic Hybridization
Array comparative genomic hybridization using a custom 180K oligonucleotide microarray was performed on a DNA sample from the affected patient with a genome-wide resolution of 100 kb. Clinically reportable results included deletions ≥200 kb and duplications ≥500 kb. deletions and base quality score recalibration were then performed using the Genome Analysis Toolkit. 20 Single nucleotide variants and insertions and deletions were called across all 4 samples simultaneously using the Genome Analysis Toolkit's UnifiedGenotyper with variant quality score recalibration. 21 The resultant variant call format files were analyzed with Qiagen's Ingenuity Variant Analysis software using an iterative filtering process. To determine rarity of variants, minor allele frequencies from 3 publicly available databases were utilized: 1000 Genomes (whole-genome sequencing data from 1092 individuals), 22 
Animals
Wild-type (WT) and Lrrc10 À/À mice in a C57BL/6N genetic background were generated and genotyped, as described previously. 18, 26 In this study, age-matched mice (3-4 months old) were used in biochemistry and whole-cell patch clamp electrophysiology studies. All procedures were performed in accordance with the Guide for the Care and Use of Laboratory Animals (National Institutes of Health) and approved by the University of Wisconsin-Madison institutional animal care and use committee (protocol M05182).
Isolation of Adult Mouse Ventricular Myocytes
Adult mouse ventricular cardiac myocytes were isolated by enzymatic digestion using 0.1 mg/mL of Blendzyme 3 (Roche) or Liberase TM (Roche), as described previously.
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Plasmids
Human LRRC10 plasmids were constructed by standard methods. Briefly, the full-length LRRC10 coding sequence was amplified by polymerase chain reaction using LRRC10 in the pCMV-SPORT6.1 vector (Open Biosystems) as a template and LRRC10 primers. The LRRC10 cDNA was then subcloned into the pcDNA3, pcDNA3.1/myc HisB(À) (Invitrogen), or pEGFP-N1 vector (Clontech) using appropriate restriction enzyme sites. The LRRC10 point mutation (I195T) was generated in the LRRC10/pCMV-SPORT6.1 vector using the QuickChange Site-Directed Mutagenesis kit (Agilent Technologies) with primers containing a nucleotide mutation (T584C). The LRRC10 mutant cDNA was amplified by polymerase chain reaction and subcloned into pcDNA3, pcDNA3.1/myc, or pEGF-N1. The sequence was verified by diagnostic restriction enzyme digest and nucleotide sequencing.
Cell Culture and Transfections
Human embryonic kidney (HEK293) cells were maintained and transfected, as described previously. 30 
Surface Biotinylation
Representative fractions of cell surface proteins were prepared, as described previously. 34 Briefly, HEK293 cells transiently expressing HA-Ca v 1.2 (Ca v 1.2, a 2 d, b 2CN2 plus T-antigen) with or without Myc-LRRC10 (WT or I195T) were treated with 0.5 to 1 mg/mL sulfo-NHS-SS-biotin for 10 minutes at 37°C. Cells were lysed in 1% Triton X-100 in PBS supplemented with protease inhibitors. Surface membrane proteins were subsequently purified using streptavidin sepharose and used for SDS-PAGE and Western blotting.
Electrophysiology
LTCC currents (I Ca,L ) were recorded from isolated ventricular myocytes and transiently transfected HEK293 cells 48 hours after transfection using the whole-cell configuration. The extracellular recording solution consisted of (in mmol/L) 1 4-aminopyridine, 1.8 CaCl 2 , 5 CsCl, 5 Glucose, 10 HEPES, 1 MgCl 2 , and 145 TEA-Cl (pH 7.4 using TEA-OH) for isolated myocytes and 10 CaCl 2 , 133 CsCl, 10 HEPES, and 5 glucose (pH 7.4 using CsOH) for recordings in HEK293 cells. Borosilicate glass pipettes were pulled to a resistance of 1.2 to 2.7 MΩ when filled with internal solution, which contained (in mmol/L) 114 CsCl, 10 EGTA, 10 HEPES, and 5 Mg-ATP (pH 7.2 using CsOH). Whole-cell currents were recorded and analyzed, as described previously. 29, 30, 35 The current-voltage protocol described previously was used for recordings in HEK293 cells, 30 and a current-voltage protocol that steps to À50 mV from a holding potential of À80 mV to inactivate any sodium current contamination followed by 10-mV depolarizations from À40 mV to +70 mV was used to record I Ca,L in isolated myocytes. Leak and capacitive currents were subtracted using a P/4 protocol and whole-cell conductance was calculated as described previously. 30, 35 In brief, the whole-cell conductance (shown as G) was calculated from the peak I Ca,L obtained in the current-voltage relationship, divided by the driving force (V test ÀV reversal ). The conductance-voltage curve was plotted and fit by a Boltzmann function to the equation
and slope value (k) are calculated. To determine the voltage dependence of I Ca,L inactivation, we used a 2-pulse protocol with a 500-ms conditioning pulse from À80 mV to +50 mV, followed by a 25-ms test pulse to +10 mV. For the steady-state inactivation data, the peak current during the test pulse was fit to a Boltzmann function using the equation
Statistical Analyses
Data are expressed as meanAESEM. Using Origin 8.6 software (OriginLab), 1-way ANOVA followed by post hoc pairwise comparisons with Bonferroni correction was performed to determine statistical significance between multiple experimental groups compared with the control group. The Student t test was used for comparisons between 2 groups. P<0.05 was considered statistically significant.
Results
Presentation of End-Stage Infantile DCM
The patient presented at 6 weeks of age in cardiogenic shock. Echocardiography demonstrated severe left ventricular enlargement and an ejection fraction of 10% to 15%. Electrocardiography revealed normal sinus rhythm and left ventricular hypertrophy with a strain pattern. Her birth history was unremarkable, and she had no dysmorphic features. Workup for infectious and metabolic etiologies was negative, leading to a diagnosis of idiopathic DCM. She was resuscitated and stabilized with mechanical ventilation and intravenous ionotropic support and eventually transitioned to an outpatient heart failure regimen of carvedilol, enalapril, and furosemide. Because of persistent, severe systolic dysfunction, she was listed for cardiac transplantation, which occurred at 4 months of age. Screening echocardiograms in her nonconsanguineous parents and older brother revealed normal left ventricular size and systolic function (father, aged 35 years; mother, aged 34 years; sibling, aged 8 years).
WES Identifies Homozygous Recessive LRRC10 Variant
Array comparative genomic hybridization excluded chromosomal aneuploidy in the patient. To identify the genetic underpinnings of her DCM, WES was performed on genomic DNA samples from the patient and her unaffected parents (Figure 1A) . Each sample yielded >120 million 101-bp, paired-end reads and passed quality control standards. More than 95% of the reads mapped to the genome, with at least 87% of the mapped reads demonstrating a read depth of ≥20. Variant call format files from the family trio were loaded into Ingenuity's Variant Analysis, and a comprehensive filtering strategy was used ( Figure 1B ). Variants with a read depth >5 that mapped to the coding region and passed variant quality score recalibration were filtered to exclude those located in the top 0.5% of the most exonically variable genes and present in ≥5 in-house, non-DCM controls. Variants were then filtered for rarity, excluding variants with a minor allele frequency ≥1.0% in the 1000 Genomes, Exome Variant Server, or ExAC databases. Next, all canonical splice-site, missense, and truncation variants were retained. Variants were then filtered to model all potential modes of inheritance, including de novo, homozygous recessive, compound heterozygous, and uniparental disomy. Comprehensive filtering resulted in only 5 candidate variants in 4 genes. De novo missense variants were identified in TTC28 (tetratricopeptide repeat domain 28) and RIMKLA (ribosomal modification protein rimK-like family member A; also known as N-acetylaspartylglutamate synthase II). TTC28 is involved in condensation of spindle midzone microtubules, formation of the midbody, and completion of cytokinesis in COS-7 and HeLa cells 36 and has low expression in the heart (left ventricle: 1.732 RPKM (reads per kilobase of sequence per million reads mapping to transcribed RNAs); highest expression: ovary, 9.205 RPKM). 25 The identified c.4062C>A, p.N1354K missense variant (NM_001145418.1) does not fall within a known functional domain, and in silico tools did not predict a deleterious effect (SIFT: 0.12=tolerated, PolyPhen2: 0.223=be-nign). 23, 24 RIMKLA catalyzes the synthesis of the neurotransmitters NAGG (N-acetylaspartylglutamate) 37 and NAGG 2 (Nacetylaspartylglutamylglutamate) 38 and is almost exclusively expressed in the central nervous system, 37 with low expression in the heart (left ventricle: 1.432 RPKM). 25 The identified confidence], PolyPhen 2: 0.141=benign). 23, 24 SSC5D expression is restricted to monocytes/macrophages and T lymphocytes, being particularly enriched in the placenta, 39 with low expression in the heart (left ventricle: 1.304 RPKM). 25 The last candidate was a homozygous recessive missense variant in LRRC10, a recently identified DCM-associated gene ( Figure 1A and 1C). The c.584T>C, p.I195T missense variant (rs151080979; NM_201550.2) is located in the sole coding exon of LRRC10, which encodes a 277-amino acid protein exclusively expressed in the heart (left ventricle: 9.96 RPKM). 25 The I195T substitution was predicted to be deleterious (SIFT: 0=damaging; PolyPhen2: 0.796=possibly damaging) 23, 24 and is located within a highly conserved LxxLxLxxNxL motif 40 (Figure 1D) . The heterozygous carrier state in the patient's parents was clinically silent. To further investigate genotype-phenotype correlation in the family, Sanger sequencing of LRRC10 was performed in the patient's unaffected 8-year-old sibling. Unexpectedly, he was found to be homozygous for the same I195T variant identified in his affected sister ( Figure 1A) . In an effort to identify a potential deleterious or beneficial modifier polymorphism that could account for variable penetrance, WES was performed on the sibling. A gene-targeted filtering scheme was then applied that compared the siblings for variants in genes (1) that are associated with DCM, 41 Figure 2A ). The voltage dependence of I Ca,L activation was determined by calculating the whole-cell conductance across a range of test potentials (À60 mV to +20 mV) and fitting the data to a Boltzmann distribution. Coexpression of the WT LRRC10 significantly shifted the voltage dependence of activation to more hyperpolarized potentials (V 1/2 of À16.2AE1.1 mV; P<0.05) compared to the LTCC complex expressed alone (V 1/2 of À12.6AE0.88 mV), whereas coexpression of the I195T LRRC10 mutation shifted the voltage dependence of activation to more depolarized potentials (V 1/2 of À8.7AE0.85 mV; P<0.05; Figure 2B ). Moreover, the Boltzmann distribution parameter, k, which reflects the slope of the activation curve, was significantly steeper with the coexpression of WT LRRC10 (k=5.6AE0.36; P<0.05) compared with the LTCC complex expressed alone (k=7.5AE0.26). The k value (k=8.3AE0.19) was not different with I195T LRRC10 coexpression. These results show that WT LRRC10 and I195T LRRC10 can affect the activation gating of LTCCs in opposing fashions.
We also analyzed the voltage dependence of steady-state inactivation of I Ca,L ( Figure 2C ). The V 1/2 of I Ca,L inactivation was not significantly different comparing LTCC complex alone (V 1/2 =À27.6AE1.1 mV), coexpression with WT LRRC10 (V 1/ 2 =À29.0AE1.1 mV), or coexpression with I195T LRRC10 (V 1/ 2 =À24.6AE1.1 mV). However, the slope factor was significantly steeper with WT LRRC10 coexpression (k=5.7AE0.28; P<0.05) but not with I195T LRRC10 coexpression (k=8.25AE0.50) relative to the LTCC complex expressed alone (k=7.8AE0.37). Moreover, we calculated the ratio of I Ca,L remaining at +20 mV (slowly inactivating current) to the maximal current (I max ) and found that coexpression of WT LRRC10 resulted in a smaller fraction of slowly inactivating I Ca,L (0.08AE0.01; P<0.05), whereas coexpression of I195T LRRC10 showed a larger fraction of slowly inactivating I Ca,L, (0.18AE0.01; P<0.05) compared with the LTCC complex expressed alone (0.12AE0.01). These differences in the inactivation of I Ca,L may contribute to increased risk of DCM with I195T producing more late I Ca,L , which could lead to increased Ca 2+ loading.
WT and I195T LRRC10 Do Not Affect the Plasma Membrane Expression of Ca v 1.2 Channel in Transiently Transfected HEK293 Cells
The changes in the I Ca,L density observed with the coexpression of WT or I195T LRRC10 could be due to changes in the surface membrane expression of Ca v 1.2 channels. To determine whether coexpression of WT or DCM-linked I195T LRRC10 affects the surface membrane expression of Ca v 1.2 channels, surface biotinylation experiments were performed using HEK293 cells transiently transfected with the LTCC complex (HA-Ca v 1.2+b 2CN2 +a 2 d) alone or with either WT or I195T LRRC10. Lysates were prepared from the biotinylated HEK293 cells and incubated overnight with streptavidin sepharose beads to purify the biotinylated plasma membrane proteins. To specifically detect the plasma membrane expression of the HA-Ca v 1.2 channels, immunoblots were incubated with anti-hemagglutinin antibody. Figure 3 shows a representative immunoblot with the starting material and cell surface fractions for each group of transfected HEK293 cells. The ratio between the cell surface and starting material fractions for the HEK293 cells coexpressing the LTCC complex with the WT or I195T LRRC10 were then normalized relative to the control (LTCC complex). Analysis of the immunoblot from 4 independent surface biotinylation experiments demonstrated no significant differences in the plasma membrane expression of Ca v 1.2 channels with coexpression of either WT or I195T LRRC10 relative to when the LTCC complex was expressed alone. No significant changes were detected in the protein expression of another membrane protein, Na + /K + ATPase.
LRRC10 Associates With and Directly Modulates Ca v 1.2 Channel Gating in HEK293 Cells
To determine whether the WT and DCM-linked I195T LRRC10 mutation associated with the Ca v 1. Figure 4B and 4C); however, coexpression of I195T LRRC10 did not result in measurable currents (n=7 transfections). Coexpression of WT LRRC10 shifted the normalized whole-cell conductance-voltage curve in the hyperpolarizing direction ( Figure 4D ): P<0.05; Figure 5A ). The voltage dependence of current activation was not significantly different between Lrrc10
and WT myocytes; however, the slope factor was significantly different between WT (k=5.2AE0.13) and Lrrc10 À/À (k=5.7AE0.11; P<0.05; data not shown). To determine whether the sex of the mice differentially affected the effect of knockout of Lrrc10, we separately analyzed the data from male and female mice. A significant reduction in I Ca,L was found in cardiomyocytes from both male and female Lrrc10 À/ À mice relative to WT mice of the same sex (data at 0 mV; Figure 5A , inset).
To determine whether loss of Lrrc10 also affected the inactivation of LTCC, we used a steady-state inactivation protocol that consisted of a 500-ms prepulse from À60 mV to +50 mV, followed by a 25-ms test pulse to +10 mV. The peak current elicited by the test pulse normalized to the maximal current (I/I max ) was plotted as a function of voltage and fitted to a Boltzmann distribution. The V 1/2 for the Lrrc10 À/À myocytes was more depolarized compared with WT (V 1/2 of À22.5AE0.44 mV versus À24.8AE0.51 mV, P<0.05), with the k value and residual current between the 2 groups unchanged ( Figure 5B ). hearts. Using the specific Ca v 1.2 LTCC antibody, we detected the previously described long and short forms of the functional channel, with the short form predominating in native cardiac tissue. [43] [44] [45] [46] Although our lysate preparation and Western blot methods allowed the detection of the long form of the channel, the corresponding %230-kDa protein bands were difficult to reproducibly quantitate. Consequently, we performed densitometry analysis using the predominant %210-kDa short form, which showed that the protein expression of Ca v 1. 
Ca v 1.2 Protein Expression is Unchanged in
Discussion
We report the use of an unbiased WES approach to uncover a homozygous recessive LRRC10 I195T variant in an infant with DCM and end-stage systolic heart failure. In addition, we demonstrated that WT LRRC10 and I195T LRRC10 associate with Ca v 1.2 channels and differentially modulate the gating of heterologously expressed LTCCs. Furthermore, knockout of Lrrc10 in mouse reduces LTCC current. These results suggest that LRRC10 is a cardiac-specific auxiliary subunit of LTCCs and that variants in LRRC10 can result in distinct differences in LTCC behavior contributing to the genesis of DCM. LRRC10 was recently selected as a candidate gene for mutation scanning in a cohort of 220 DCM patients based on its cardiac-restricted expression and animal knockout studies. Two heterozygous missense mutations were identified (L41V and L163I), associating LRRC10 with adult-onset, familial DCM segregating as an autosomal dominant trait. 7 These heterozygous LRRC10 mutations reported by Qu et al are absent in the ExAC database and were identified in individuals ranging in age from 29 to 61 years, all of whom fulfilled diagnostic criteria for DCM. 7 By contrast, the heterozygous carrier state of the LRRC10 I195T variant in the patient's parents, both in their mid-30s, was clinically silent. They may develop heart failure later in life, particularly if they acquire additional risk factors. Indeed, LRRC10 is required to maintain cardiac performance in response to pressure overload, 47 implying that mutations in LRRC10 may greatly sensitize human patients to severe cardiomyopathy in the setting of Figure 6 . pressure overload, such as in patients with high blood pressure or aortic stenosis. Heterozygosity for the I195T (rs151080979) variant of LRRC10 is present in 0.56% of %60 000 individuals (European descent: 0.77%, n=73 324 alleles; non-European descent: 0.24%, n=48 016 alleles) of unknown cardiac phenotype in the ExAC database, suggesting it may not be sufficiently pathogenic for DCM but may confer susceptibility to heart failure, given its functional impact on LTCC. Unexpectedly, the identified variant was also present in the homozygous state in the patient's clinically unaffected brother, as well as 2 individuals of unknown age in the ExAC database (frequency: 0.003%), suggesting that even the homozygous state can have variable, age-dependent penetrance 48 and that development of DCM may require additional inherited or acquired risk factors. We considered sex as a possible factor accounting for the variable phenotypes of the female proband and her brother, both of whom were homozygous for the I195T LRRC10 variant, by evaluating for sex-dependent differences in the Lrrc10 LTCCs by LRRC10 and other Ca 2+ channel subunits could contribute to phenotypic differences. Additional unknown modifiers in coding or noncoding regions not covered by WES, epigenetic factors, or environmental differences cannot be excluded. Variable age-dependent penetrance is known to occur in DCM family members carrying the same mutation, highlighting the possibility that the clinically unaffected sibling may develop DCM as a teenager or adult. 41 Analysis of additional participants with the I195T LRRC10 variant in the future is necessary to firmly establish and understand the association between the I195T LRRC10 and DCM. The results suggest a possible link between the I195T LRRC10 mutation and the DCM phenotype based on the dramatically different effects of WT LRRC10 and I195T LRRC10 on heterologously expressed LTCCs. While WT LRRC10 shifted the voltage dependence of activation in the hyperpolarizing direction, leading to larger currents over the physiological range of the action potential, I195T LRRC10 shifted the activation voltage to more positive potentials and led to smaller currents. Moreover, coexpression of WT LRRC10 with Ca v 1.2 in the absence of auxiliary b and a 2 d subunits resulted in significantly larger I Ca,L and a hyperpolarizing shift in the voltage dependence of I Ca,L activation, suggesting that although LRRC10 may not affect Ca v 1.2 channel trafficking, it could still modulate the gating of the channels. Dysregulation of calcium homeostasis by genetic mutations or alteration in the function, localization, and expression of calcium-handling proteins has been implicated in many cardiac diseases such as pathological cardiac hypertrophy, heart failure, and DCM. 19, [51] [52] [53] [54] [55] Although the impact of loss of Lrrc10 in the Lrrc10 À/À mouse on I Ca,L is more subtle, there is a consistent decrease in I Ca,L in the knockouts. Furthermore, the distinct complement of regulatory proteins, subunits, and posttranslational modifications of LTCCs could contribute to the differences between the effects in heterologously expressed channels and those in native cardiomyocytes.
There is precedence for LRRC proteins acting as modulators of ion channel function, and specifically, a subset of LRRC proteins have been defined as c subunits for large conductance, calcium, and voltage-activated potassium (BK) channels. The effects of the LRRC proteins on channel function can be striking, such as LRRC26 causing a %140-mV negative shift in the voltage dependence of activation of BK channels. 10 The LRRC26 paralogues, LRRC52, LRRC55, and LRRC38 have also been identified as BK-c subunits. 11, 12, 56 In addition, LRRC52
has also been demonstrated to be a regulatory protein for Slo3 channels in sperm cells. 57 The BK-c subunit LRRCs are composed of an intracellular C-terminus, a transmembrane segment and an extracellular LRRC region. 11 However, LRRC10
is an intracellular protein without a predicted transmembrane domain, making it more comparable to cytoplasmic Ca v b auxiliary subunits. Furthermore, LRRC10's localization near the Z-line in adult myocytes is consistent with it acting as a subunit of dyadic localized LTCCs. LRR motifs are known to facilitate strong protein-protein interactions. Our co-IP and Western blot experiments in transiently transfected HEK293 cells demonstrate an association of LRRC10 and the Ca v 1.2 channel subunit. Co-IP experiments using WT mouse heart lysates further confirm an association between Ca v 1.2 and LRRC10 in native tissue. However, the direct binding partner for LRRC10 in the Ca v 1.2 macromolecular complex in the heart requires further investigation. How does it affect LTCC gating? In addition, it is also possible that LRRC10 has other binding partners and functions besides regulating LTCCs in cardiomyocytes that have yet to be determined. Overall, the role of LRRC10 in cardiac function and DCM is only beginning to be deciphered, and a new link between LRRC10 and LTCCs provides new avenues for understanding.
